Abortion rights supporters hail win for evidence-backed medicine as Evita Solutions’ generic version of mifepristone given approval

In a move that has left anti-abortion advocates reeling, the US Food and Drug Administration (FDA) quietly approved a request to manufacture a new abortion pill earlier this week.

Thanks to the approval, a company called Evita Solutions will be able to manufacture its generic version of mifepristone, one of two drugs typically used in most US medication abortions. A generic version of mifepristone, which was first approved as a brand-name drug in 2000, is already available on the market.

Continue reading…

Follow the latest news live

Opposition leader Sussan Ley has expressed her “grief and shock” after the Manchester synagogue attack. She said in a statement this morning:

Our thoughts are with the families of those who have been killed and injured in this cowardly, evil attack.

The threat of terrorism requires continual vigilance and courage from our police and first responders. To target worshippers and families as they gather together for the holiest period of the Jewish faith is despicable beyond words. All people, regardless of religion have the right to worship in peace and should feel they can do so without fear or apprehension.

Continue reading…

Experts point to study showing procedures at home are no risker or less successful than hospital care

At-home abortions should be allowed for up to 12 weeks of pregnancy across the UK, according to academics, after a study found they were just as safe and effective as hospital care.

A medical abortion involves taking two medications, mifepristone and misoprostol, to end a pregnancy. In 2022, at-home medical abortions were made permanent in England and Wales, after temporary legislation allowed them to take place at home during the pandemic. In Northern Ireland, at-home abortion care is not permitted at any gestation.

Continue reading…